Sorrento Therapeutics (SRNE)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q2 2023 | |||||
| ≡ | Howard Marks - Oaktree Capital Management | Sell 100.00% | 134,000 | 0.00 | |
| Q2 2022 | |||||
| ≡ | Howard Marks - Oaktree Capital Management | Reduce 10.67% | 16,000 | 0.00 | |
| Q2 2021 | |||||
| ≡ | Howard Marks - Oaktree Capital Management | Reduce 58.13% | 186,000 | 0.03 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Sell 100.00% | 27,838 | 0.01 | |
| Q3 2020 | |||||
| ≡ | David Katz - Matrix Asset Advisors | Sell 100.00% | 50,000 | 0.06 | |
| ≡ | Howard Marks - Oaktree Capital Management | Sell 100.00% | 100,500 | 0.02 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.